Healthcare is an industry driven by evidence. While a consumer market exists for mobile health, the overwhelming majority of healthcare expenditure is through formalised reimbursement mechanisms, typically funded by governments, insurers or employers. To justify payment, these organisations generally require formal evaluation of robust technical and clinical evidence with the hope of demonstrating a “health currency” which quantifies the health impact, cost and access issues of a particular intervention.
The GSMA believes one of the barriers to large-scale deployments of mHealth is this lack of clinical evidence. To help Operators understand and overcome this barrier, we have undertaken a series of initiatives including working with A T Kearney to publish a whitepaper called Improving the Evidence for Mobile Health. This paper first evaluates the current state of mobile health evidence and then outlines how stakeholders can generate relevant, high quality evidence that can be used to recommend mobile health services.
In preparing the report, A T Kearney undertook an extensive analysis of the PubMed database to identify and extract all relevant articles and whitepapers on the subject of mHealth and evidence. We want make these relevant documents easily accessible to assist all working in this space. To access our Evidence Knowledge Bank, click here
About PubMed
PubMed is a renowned repository of over 21 million citations for biomedical literature form MEDLINE, life science journals and online books. PubMed is a free resource that is developed and maintained by the National Center for Biotechnology Information (NCBI) at the US National Library of Medicine (NLM) located at the National Institutes of Health (NIH).
